Abstract:Yingda Lin, 1, 2, &ast Fuming He, 2 Ling Wu, 1 Yuan Xu, 1 Qiu Du 3, 4, &ast 1 Department of Pharmacy, the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225012, People's Republic of China; 2 Medical College, Yangzhou University, Yangzhou, 225001, People's Republic of China; 3 Department of Neurosurgery, the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225012, People's Republic of China; 4 Department of Central Laboratory, the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225012, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qiu Du, Department of Neurosurgery, the Affiliated Hospital of Yangzhou University, Yangzhou University, 368 Hanjiang Middle Road, Yangzhou, 225012, People's Republic of China, Email Yuan Xu, Department of pharmacy, the Affiliated Hospital of Yangzhou University, Yangzhou University, 368 Hanjiang Middle Road, Yangzhou, 225012, People's Republic of China, Email As The main effective monomer of the traditional Chinese medicine Sophora flavescens Ait , matrine has a broad scope of pharmacological activities such as anti-tumor, anti-inflammatory, analgesic, anti-fibrotic, anti-viral, anti-arrhythmia, and improving immune function. These actions explain its therapeutic effects in various types of tumors, cardiopathy, encephalomyelitis, allergic asthma, rheumatoid arthritis (RA), osteoporosis, and central nervous system (CNS) inflammation. Evidence has shown that the mechanism responsible for the pharmacological actions of matrine may be via the activation or inhibition of certain key molecules in several cellular signaling pathways including the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR), transforming growth factor-β/mothers against decapentaplegic homolog (TGF-β/Smad), nuclear factor kappa B (NF-κB), Wnt (wingless/ integration 1)/β-catenin, mitogen-activated protein kinases (MAPKs), and Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathways. This review comprehensively summarizes recent studies on the pharmacological mechanisms of matrine to provide a theoretical basis for molecular targeted therapies and further development and utilization of matrine. Keywords: matrine, pharmacological effects, signaling pathways, review Sophora flavescens Ait is a well-known traditional Chinese herbal medicine and has been widely utilized in the clinical practice for its effects on various damp-heat syndromes, heat-toxin syndromes like carbuncle and sore, and skin itching. 1 Modern pharmacological studies have shown that matrine (molecular formula: C15H24N2O, molecular weight: 248.36 g/mol) is a naturally occurring quinolizidine alkaloids rich in Sophora flavescens Ait as well as Sophora alopecuroides Linn, Sophora tonkinensis , which mediates a variety of biological effects such as anti-tumor, anti-inflammatory, analgesic, anti-fibrotic, anti-viral, anti-arrhythmia, antimicrobial, and insecticidal, illustrating that it has immense potential for clinical application with various pharmacological activities. 1,2 At present, studies have reported that the pharmacological effects of matrine involve the PI3K/AKT/mTOR, TGF-β/Smad, NF-κB, Wnt/β-catenin, MAPKs, JAK/STAT, and other significant signaling pathways, and closely related to multiple biological processes such as cell proliferation, differentiation, apoptosis, and immune regulation. 1–3 However, few studies have classified and summarized the underlying molecular mechanisms by which matrine exerts its pharmacological effects through different signaling pathways. In this review, the pharmacological activities of matrine and the molecular mechanisms of its pharmacological effects through the targeted regulation of different signaling pathways will be comprehensively expounded, so as to provide theoretical support for further expanding the potential clinical application of matrine. PI3K is a heterodimeric lipid kinase composed of a catalytic subunit (p110α, p110β, or p110δ; encoded by the PIK3CA, PIK3CB, and PIK3CD genes, respectively) and a regulatory subunit (p85). 4 PI3K is mainly activated by receptor tyrosine kinase (RTK) signaling, via phosphorylation of the inositol lipid phosphatidylinositol 4, 5-bisphosphate (PI (4, 5) P2). It then forms the second messenger molecule phosphatidylinositol (3, 4, 5)-trisphosphate (PI (3, 4, 5) P3) that recruits and activates pleckstrin homology (PH) domain-containing proteins such as AKT and phosphoinositide-dependent kinases (PDK) 1, which leads to downstream signaling -Abstract Truncated-

Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review

Effects of Matrine and Oxymatrine on Catalytic Activity of Cytochrome P450s in Rats.

Matrine Induces Caspase-Dependent Apoptosis in Human Osteosarcoma Cells in Vitro and in Vivo Through the Upregulation of Bax and Fas/FasL and Downregulation of Bcl-2

Toxic Markers of Matrine Determined Using (1) H-NMR-Based Metabolomics in Cultured Cells In Vitro and Rats In Vivo.

Toxic Markers Of Matrine Determined Using H-1-Nmr-Based Metabolomics In Cultured Cells In Vitro And Rats In Vivo

Matrine Inhibits Invasiveness and Metastasis of Human Malignant Melanoma Cell Line A375 in Vitro

Research progress of matrine's anticancer activity and its molecular mechanism

Matrine: A Promising Natural Product With Various Pharmacological Activities

Matrine inhibits the growth of natural killer/T-cell lymphoma cells by modulating CaMKIIγ-c-Myc signaling pathway

Matrine induces apoptosis in acute myeloid leukemia cells by inhibiting the PI3K/Akt/mTOR signaling pathway

A Systematic Review of the Pharmacology, Toxicology and Pharmacokinetics of Matrine

Matrine inhibits the development and progression of ovarian cancer by repressing cancer associated phosphorylation signaling pathways

MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway

Matrine induces autophagic cell death by triggering ROS/AMPK/mTOR axis and apoptosis in multiple myeloma

Chinese traditional medicine matrine: A review of its antitumor activities

Matrine injection inhibits pancreatic cancer growth via modulating carbonic anhydrases- a network pharmacology-based study with in vitro validation

Integrating network pharmacology and Mendelian randomization to explore potential targets of matrine against ovarian cancer

Matrine inhibits vascular smooth muscle cell proliferation by modulating the expression of cell cycle regulatory genes

Matrine-Type Alkaloids Inhibit Advanced Glycation End Products Induced Reactive Oxygen Species-Mediated Apoptosis of Aortic Endothelial Cells In Vivo and In Vitro by Targeting MKK3 and p38MAPK Signaling.

Matrine involves in the progression of gastric cancer through inhibiting miR-93-5p and upregulating the expression of target gene AHNAK

Matrine is Identified As a Novel Macropinocytosis Inducer by a Network Target Approach